Identifying simultaneous inhibition of riboflavin metabolism and MEK as a novel therapeutic strategy for pancreatic cancerTakako Ooshio, Masahiro Sonoshita|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1